Vaxcyte, Inc.
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All PCVX news ›Vaxcyte Bolsters Capital Structure with New Offerings
Vaxcyte ( (PCVX) ) has provided an announcement. The most recent analyst rating on (PCVX) stock is a Hold with a $85.00 price target. To see the full list of analyst forecasts on Vaxcyte stock, see the PCVX Stock Forecast page. Spark’s…
Vaxcyte (PCVX) Stock Soars As VAX-31 Data Smash Expectations
Vaxcyte Inc. stocks have been trading up by 8.72 percent amid strong vaccine pipeline progress boosting investor optimism. PCVX just went from quiet grind to momentum name. Over the past couple of weeks, Vaxcyte stock mostly chopped in the…
Vaxcyte PCVX Soars As VAX-31 Phase 3 Data Stun Wall Street
Vaxcyte Inc. stocks have been trading up by 8.52 percent following strong clinical progress and heightened vaccine market optimism. PCVX has been trading like a biotech on the edge of a major re-rating — because that is exactly what is…
Vaxcyte Inc Stock (PCVX) Moved Up by 9.47% on Oct 9: What Signal Does It Send?
TradingKey Vaxcyte Inc Stock (PCVX) Moved Up by 9.47% on Oct 9: What Signal Does It Send? What is driving Vaxcyte Inc (PCVX)’s stock price up today? The strong upward momentum in Vaxcyte shares is primarily driven by groundbreaking…
Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares and Convertible Senior Notes
Investing News Network Vaxcyte Announces Closing of $1.15 Billion Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares and…
Analysts Conflicted on These Healthcare Names: BridgeBio Pharma (BBIO) and Vaxcyte (PCVX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on BridgeBio Pharma (BBIO) and Vaxcyte (PCVX). In a report released yesterday, Whitney Ijem from Canaccord Genuity maintained a Buy rating on BridgeBio Pharma,…
Vaxcyte’s 31-strain pneumococcal conjugate vaccine passes phase 3 test
Vaccine maker Vaxcyte this week announced positive topline results from a phase 3 trial of its investigational 31-valent (31-strain) pneumococcal conjugate vaccine (PCV) candidate, VAX-31. VAX-31 was designed to prevent serious and…
Vaxcyte Closes Offerings of Common Stock, Warrants, and Senior Notes
marketscreener.com Biotechnology & Medical Research Vaxcyte Closes Offerings of Common Stock, Warrants, and Senior Notes Published on 10/09/2026 at 04:28 pm EDT
Vaxcyte Raises $1.10B in Concurrent Offerings; Signs $575M 1.50% Convertible Notes Indenture and UAs
TradingView Agreement 1: Vaxcyte Closes $575 Million 1.50% Convertible Notes Due 2032 Under New Indenture Agreement 2: Vaxcyte Executes Equity Underwriting Agreement for Stock and Pre-Funded Warrants Agreement 3: Vaxcyte Executes Debt…
Vaxcyte Finalizes $575M Convertible Senior Notes and Equity Offering in October 2026
Where Does Semtech Fit in the AI Data Center Build-Out? Where Does Apple Fit as Services Grow Alongside the iPhone? What Does Moderna's Cancer Vaccine Work Mean Beyond COVID? Why Is Varonis Putting Data at the Center of Security? On…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
stocktitan.net27
-
marketscreener.com22
-
tradingview.com11
-
finance.yahoo.com9
-
investingnews.com5
Measured across the 4Arizona news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.